Silverfin false false 31/08/2024 01/09/2023 31/08/2024 R Nagioff 04/12/2018 30 June 2025 The principal activity of the company for the financial year was that of a holding company. 11711129 2024-08-31 11711129 bus:Director1 2024-08-31 11711129 2023-08-31 11711129 core:CurrentFinancialInstruments 2024-08-31 11711129 core:CurrentFinancialInstruments 2023-08-31 11711129 core:ShareCapital 2024-08-31 11711129 core:ShareCapital 2023-08-31 11711129 core:RetainedEarningsAccumulatedLosses 2024-08-31 11711129 core:RetainedEarningsAccumulatedLosses 2023-08-31 11711129 core:CostValuation 2023-08-31 11711129 core:CostValuation 2024-08-31 11711129 bus:OrdinaryShareClass1 2024-08-31 11711129 2023-09-01 2024-08-31 11711129 bus:FilletedAccounts 2023-09-01 2024-08-31 11711129 bus:SmallEntities 2023-09-01 2024-08-31 11711129 bus:AuditExemptWithAccountantsReport 2023-09-01 2024-08-31 11711129 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 11711129 bus:Director1 2023-09-01 2024-08-31 11711129 2022-09-01 2023-08-31 11711129 bus:OrdinaryShareClass1 2023-09-01 2024-08-31 11711129 bus:OrdinaryShareClass1 2022-09-01 2023-08-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 11711129 (England and Wales)

RN FUSION LIMITED

Unaudited Financial Statements
For the financial year ended 31 August 2024
Pages for filing with the registrar

RN FUSION LIMITED

Unaudited Financial Statements

For the financial year ended 31 August 2024

Contents

RN FUSION LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 August 2024
RN FUSION LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 August 2024
Note 2024 2023
£ £
Fixed assets
Investments 3 17 17
17 17
Current assets
Debtors 4 8,978,400 6,994,399
Cash at bank and in hand 15,414 23
8,993,814 6,994,422
Creditors: amounts falling due within one year 5 ( 1,155,765) ( 1,608,333)
Net current assets 7,838,049 5,386,089
Total assets less current liabilities 7,838,066 5,386,106
Net assets 7,838,066 5,386,106
Capital and reserves
Called-up share capital 6 4 4
Profit and loss account 7,838,062 5,386,102
Total shareholder's funds 7,838,066 5,386,106

For the financial year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of RN Fusion Limited (registered number: 11711129) were approved and authorised for issue by the Director. They were signed on its behalf by:

R Nagioff
Director

30 June 2025

RN FUSION LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2024
RN FUSION LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 August 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

RN Fusion Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the company's registered office is 35 Ballards Lane, London, N3 1XW, United Kingdom.

The principal activity of the company for the financial year was that of a holding company.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Fixed asset investments

Investments are recognised initially at fair value which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through profit or loss if the shares are publicly traded or their fair value can otherwise be measured reliably. Other investments are measured at cost less impairment.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to and from related parties and investments in non-puttable ordinary shares.

Financial assets
Basic financial assets, including trade and other debtors are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings.

Financial assets are derecognised when (a) the contractual rights to the cash flows from the asset expire or are settled, or (b) substantially all the risks and rewards of the ownership of the asset are transferred to another party or (c) control of the asset has been transferred to another party who has the practical ability to unilaterally sell the asset to an unrelated third party without imposing additional restrictions.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the company during the year, including the director 1 1

3. Fixed asset investments

Investments in associates Other investments Total
£ £ £
Cost or valuation before impairment
At 01 September 2023 16 1 17
At 31 August 2024 16 1 17
Carrying value at 31 August 2024 16 1 17
Carrying value at 31 August 2023 16 1 17

4. Debtors

2024 2023
£ £
Corporation tax 0 23,376
Other debtors 8,978,400 6,971,023
8,978,400 6,994,399

5. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 2,250 2,250
Amounts owed to director 1,146,772 1,606,069
Taxation and social security 6,005 0
Other creditors 738 14
1,155,765 1,608,333

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
4 Ordinary shares of £ 1.00 each 4 4